Close Menu

X Prize Foundation

NEW YORK (GenomeWeb News) – The X Prize Foundation has decided to cancel the Archon Genomics X Prize, saying that the plummeting cost of sequencing a genome had rendered the competition moot.

The Archon Genomics X Prize, backed by a new sponsor, has revised the guidelines for the competition to reflect its interest in attaining a "medical grade genome," the X Prize Foundation said this week.

Earlier this month, the X Prize Foundation appointed Grant Campany as senior director for the Archon Genomics X Prize. The prize offers a $10 million cash award to the first team to sequence 100 human genomes in 10 days or less for a maximum of $1 million in total costs.

Cracker becomes the first Asia-based contender for the $10 million prize and eighth contender overall.

At a meeting this week, researchers and others discussed the regulatory oversight needed for germline genome editing.

The US Food and Drug Administration has asked questions about Myriad Genetics' GeneSight test, according to Bloomberg.

Researchers report that neutrophil extracellular traps appear to binds gallstones together, according to New Scientist.

In Science this week: approach to infer genotype-by-environment interaction from genetic variants associated with phenotypic variability, and more.